The global calprotectin testing market is poised for exceptional expansion, with projections indicating a surge to a valuation of USD 360.2 billion by 2033, according to recent market analysis. This meteoric rise, which marks a robust compound annual growth rate (CAGR) of 6% during the forecast period, underscores the growing significance of calprotectin testing in the healthcare landscape.
Calprotectin testing, a vital diagnostic tool, has garnered substantial attention in the healthcare sector due to its effectiveness in detecting gastrointestinal disorders. The escalating prevalence of such disorders, coupled with an increased emphasis on early detection, has propelled the demand for calprotectin testing worldwide.
Get The Sample Copy Of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14504
The robust growth in the calprotectin testing market can be attributed to advancements in diagnostic technologies, increased research and development activities, and a growing emphasis on preventive healthcare measures. As healthcare providers and consumers alike recognize the value of early detection and diagnosis, calprotectin testing is poised to play a pivotal role in shaping the future of diagnostic healthcare.
Commenting on this trend, Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) stated, “The substantial growth projections for the global calprotectin testing industry underscore the importance of innovative diagnostic solutions in the healthcare landscape. As we witness an increased focus on preventive healthcare, calprotectin testing is positioned to be a key player in early detection and monitoring of gastrointestinal disorders. Our commitment to advancing healthcare technologies aligns with the growing demand for reliable and efficient diagnostic tools, and we are excited to contribute to the transformative journey of the calprotectin testing industry.”
As a leading player in the healthcare industry, FMI remains at the forefront of innovation, continually striving to meet the evolving needs of healthcare professionals and patients. The company’s dedication to research and development, coupled with a commitment to quality, positions it as a key contributor to the remarkable growth anticipated in the global calprotectin testing market.
Recent Trends in the Global Calprotectin Testing Market:
The several notable trends in the global market are as follows:
- There is rising demand for non-invasive diagnostic devices by healthcare providers and patients to produce quick and accurate results.
- The prevalence of inflammatory bowel disease is growing rapidly. Therefore, the demand for calprotectin testing is increasing to monitor patients’ chronic health.
- The innovation of advanced technology devices is more reliable and tract patients’ health accurately.
- Adopting automation in calprotectin testing reduces error risk, detects efficiently, and increases productivity.
Ask for Customize Research Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14504
Key Takeaways:
- The calprotectin testing market is securing a valuation of USD 360.2 billion with a CAGR of 6% by 2033.
- The United States is anticipated to lead the global market by registering a share of 25.7% by 2033.
- Japan is anticipated to register a share of 3.1% in the global market during the forecast period.
- In the historic period, the market captured a CAGR of 5.3% between 2018 and 2022.
Key Players are Executing Plans to Rise the Market Size:
The key players are executing various plans to upsurge the global market are:
- New Product Launches: key players are developing user-friendly, sustainable, and accurate testing devices in the market. They are launching these testing tools to satisfy patients’ requirements.
- Collaboration:Key companies collaborate with stakeholders, research organizations, and hospitals to enhance product quality. These collaborations help them to reach relevant customers and increase sales.
- Promotions and Marketing:Key players invest in promotional and marketing to expand their business and brand value. They promote their products on social media and educate patients about the benefits of their products.
These are a few strategies key players adopt to increase the market size:
- Actim Oy
- Calpro AS
- BÜHLMANN Laboratories AG
- EagleBio
- CerTest Biotec S.L.
- EUROIMMUN Medizinische Labordiagnostika AG
- Boditech Med Inc.
- Biohit Oyj
- American Laboratory Products Company, Ltd.
- DIAsource ImmunoAssays S.A
- R-Biopharm AG.
Recent Developments in the Global Market are:
- In 2020, Biohit Oyj launched its new product Calprotectin ELISA kit. It is designed to collect human samples to monitor inflammatory bowel disease.
- In 2021, Techlab Inc launched Enteric BioFire FilmArray Panel to detect gastrointestinal infections.
- In 2021, EKF Diagnostics launched its point-of-care device to measure calprotectin. This device provides accurate and fast results to monitor patients’ diseases.
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/14504
Calprotectin Testing Market by Category:
By Test Kits:
- Calprotectin ELISA Test Kits
- Calprotectin Rapid Testing Kits
By Sample:
- Stool, Blood Serum/Plasma
- Other Biological Samples
By Indication:
- Irritable Bowel Syndrome
- Ulcerative Colitis
- Crohn’s Disease
- Colorectal Cancer
By End User:
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube